# Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial

> **NCT00071708** · — · APPROVED_FOR_MARKETING · sponsor: **Eli Lilly and Company**

## Conditions studied

- Major Depressive Disorder
- Fibromyalgia
- Diabetic Peripheral Neuropathic Pain
- Generalized Anxiety Disorder

## Interventions

- **DRUG:** Duloxetine Hydrochloride

## Key facts

- **NCT ID:** NCT00071708
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00071708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00071708, "Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00071708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*